Oncology Venture offentliggör idag ett tillägg till prospektet publicerat 5 april 2019.

NEXT STORY
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
PREV STORY
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioAdaptives, Inc Names Dr. James Rouse as President

LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. ...

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results

-- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action ...

author_avatar
NASDAQ Market News

ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program

RICHMOND, Va., Nov. 17, 2015 (GLOBE NEWSWIRE) -- A 10-month pilot of the ALRT ...

author_avatar
NASDAQ Market News